Axsome Therapeutics Inc. (AXSM)
109.90
-1.77 (-1.59%)
At close: Apr 02, 2025, 3:59 PM
109.26
-0.58%
After-hours: Apr 02, 2025, 04:45 PM EDT
Axsome Therapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| PE Ratio | -14.11 | -15.11 | -15.86 | -10.53 | -28.76 | -50.46 | -2.45 | -4.4 | -4.75 | -10.49 | -18.52 | -51.3 |
| PEG Ratio | -1.03 | -1.79 | -0.45 | -0.39 | -0.76 | -0.64 | 0.26 | 0.42 | -0.08 | -0.12 | -0.1 | n/a |
| PS Ratio | 10.51 | 13.36 | 62.67 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 71.10 | 18.93 | 28.62 | -3.47 | -10.87 | -19.99 | -0.7 | -1.66 | -2.71 | -5.89 | -34.71 | -54.82 |
| P/FCF Ratio | -31.5 | -24.82 | -26.75 | -13.09 | -38.61 | -75.8 | -2.52 | -4.81 | -6.04 | -14.85 | -24.18 | -68.15 |
| P/OCF Ratio | -31.57 | -24.92 | -26.91 | -13.13 | -38.64 | -75.82 | -2.52 | -4.82 | -6.07 | -14.89 | -24.18 | -68.15 |
| OCF/S Ratio | -0.33 | -0.54 | -2.33 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 3.36 | 0.98 | 0.86 | -0.12 | -0.18 | -0.11 | -0.06 | -0.13 | -0.2 | n/a | -1.4 | -1.89 |
| Quick Ratio | 2.04 | 3.52 | 2.50 | 3.75 | 7.85 | 9.00 | 1.41 | 2.90 | 5.30 | 18.63 | 2.82 | 0.51 |
| Current Ratio | 2.11 | 3.63 | 2.54 | 3.75 | 7.85 | 9.00 | 1.41 | 2.90 | 5.30 | 18.63 | 2.82 | 0.51 |
| Asset Turnover | 0.68 | 0.46 | 0.15 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | -42.71 | -35.93 | -24.06 | -21.89 | -38.64 | -54.25 | -29.14 | -20.27 | -207.99 | -10.05 | -2.54 | -5.62 |
| Return on Equity | -5.04 | -1.25 | -1.81 | 0.33 | 0.38 | 0.40 | 0.29 | 0.38 | 0.57 | 0.56 | 1.87 | 1.07 |
| Return on Assets | -0.51 | -0.41 | -0.6 | 0.40 | -0.57 | -0.32 | -2.01 | -0.81 | -0.71 | -0.22 | -2.15 | -1.03 |
| Return on Invested Capital | -0.82 | -0.52 | -0.79 | -1.98 | -0.62 | -0.35 | -4.59 | -1.07 | -0.9 | -0.22 | -1.83 | -0.15 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 0.91 | 0.90 | 0.90 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -0.74 | -0.88 | -3.95 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -0.74 | -0.88 | -3.74 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -0.73 | -0.86 | -3.53 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -33.36 | -53.83 | -234.25 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -0.73 | -0.83 | -3.48 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |